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Abstract
Skeletal muscle (SKM) atrophy is a potentially debilitating condition induced by muscle
disuse, denervation, many disease states, and aging. The ubiquitin proteasome pathway (UPP)
contributes greatly to the protein loss suffered in muscle atrophy. The MERG1a K+ channel is
known to induce UPP activity and atrophy in SKM. It has been further demonstrated that the
mouse ether-a-gogo-related gene (Merg)1a channel modulates expression of MURF1, an E3
ligase component of the UPP, while it does not affect expression of the UPP E3 ligase
Mafbx/ATROGIN1. Because the UBR2 E3 ligase is known to participate in SKM atrophy, we
have investigated the effect of Merg1a expression and hind limb suspension on Ubr2
expression. Here, we report that hind limb suspension results in a significant 25.6% decrease in
mouse gastrocnemius muscle fiber cross sectional area (CSA) and that electro-transfer of
Merg1a alone into gastrocnemius muscles yields a 15.3% decrease in CSA after 7 days. More
interestingly, we discovered that hind limb suspension caused a significant 8-fold increase in
Merg1a expression and a significant 4.7-fold increase in Ubr2 transcript after 4 days, while
electro-transfer of Merg1a into gastrocnemius muscles resulted in a significant 6.2-fold
increase in Merg1a transcript after 4 days but had no effect on Ubr2 expression. In summary,
the MERG1a K+ channel, known to induce atrophy and MURF1 E3 ligase expression, does not
affect UBR2 E3 ligase transcript levels. Therefore, to date, the MERG1a channel’s
contribution to UPP activity appears mainly to be through up-regulation of Murf1 gene
expression.
Key Words: Skeletal muscle atrophy; UBR2; E3-II; ERG1a potassium channel; hind limb
suspension; E3 ligase; ubiquitin proteasome pathway
Eur J Trans Myol - Basic Appl Myol 2014; 24 (3): 173-179

which activate ubiquitin; E2 ubiquitin-conjugating
molecules which accept the activated ubiquitin and
interact with specific E3 enzymes; and the E3 ligase
which binds target protein molecules and catalyzes the
transfer of the ubiquitin from E2 to the E3-bound
protein.7,8 A minimum of four ubiquitin molecules are
required to be ligated to the target protein before it is
degraded by the 26S proteasome. To date, only a few
members of the E1 family have been identified (only
two E1 enzymes have been detected within the human
proteome) and over 50 E2 enzymes have been reported;
however, several hundred potential E3 ligases have
been described within mammalian genomes. Two main
types of E3 enzymes have been described: the
“homologous with E6-associated protein C6 terminus”
(HECT) domain enzymes and the larger family of

Skeletal muscle (SKM) can comprise 30-50% of body
weight in humans and it functions in body movement,
maintenance of posture and balance, soft tissue support,
bolster of body entry and exit points and in temperature
regulation. The loss of SKM mass and strength is
referred to as atrophy and is known to result from
unweighting, injury, denervation, disuse, disease (e.g.,
diabetes, cancer, etc.) and aging.1-5 Atrophy occurs
when there is an imbalance in the processes of protein
synthesis and protein degradation that favors protein
loss. Numerous cellular pathways can contribute to
SKM atrophy, including calpains, cathepsins and the
ubiquitin proteasome pathway (UPP).2,4 The UPP is
reported to be responsible for as much as 75% of the
protein degradation that occurs during SKM atrophy2,4,6
It is composed of three basic enzymes: E1 proteins
- 173 -

Hind Limb Suspension, but not Merg1a, Yields Ubr2 Expression
Eur J Trans Myol - Basic Appl Myol 2014; 24 (3): 173-179

“really interesting new gene” (RING) finger scaffold
proteins. A newer described group of proteins with
ubiquitin ligase activity, having atypical RING finger
moieties,9 have been described and are often referred to
as E4 enzymes. These have been reported to work in
concert with E3 proteins to enhance their activity.10
A number of E3 ligases have been identified as
contributors to atrophy in SKM. Muscle ring finger-1
(MURF1)
and
Muscle
Atrophy
F-box
(Mafbx)/ATROGIN1 are RING finger E3 ligases
specific to striated muscle that have been detected in
several models of SKM atrophy, including
unweighting, and are considered markers of
atrophy.1,2,4 Ubiquitin ring-type (UBR, also referred to
as E3) proteins are RING finger E3 ligases that are
also reported to function in atrophic SKM, specifically
cachexia-induced atrophy.11 The UBR box family of
RING finger E3 ubiquitin ligases is composed of
enzymes which recognize substrate proteins that have
an N-degron; that is, the protein to be degraded has: 1)
a destabilizing N-terminal residue; and 2) an internal
lysine residue for ubiquitination.7,12,13 These enzymes
are often referred to as N-recognins and this pattern of
protein degradation, referred to as the N-end rule
pathway, relates the identity of the N-terminal amino
acid of a protein to its half-life in vivo7,13,14 UBR1 (also
E3-I) was the first E3 ligase implicated in SKM
atrophy14,15 and is believed to bind proteins that
commence with unblocked hydrophobic or basic
amino acids.7, 16-19 The UBR2 (also E3-II) member of
the UBR family was described by Varshavsky and coworkers.17 In 2004, Kwak et al. demonstrated that both
the Ubr1 and 2 homologues are up-regulated in the
atrophying SKM of rats bearing malignant tumors.11
However, it was concluded that the UBR2 isoform is
more critically involved in the process because it is
more specifically expressed in SKM tissue and is
detected at the early onset of atrophy while UBR1 is
not. In fact, a recent study suggests that tumor cellinduced up-regulation of Ubr2 expression in skeletal
muscle may be mediated by the p38-C/EBP
signaling pathway. 19
The ether-a-gogo- related gene (ERG)1a K+ channel is
known to be partially responsible for late phase
repolarization of the cardiac action potential in many
mammalian species, including mice and humans.21 Our
laboratory has demonstrated that this channel is upregulated in the SKM of mice experiencing atrophy as
a result of both hind limb suspension (unweighting)
and cancer cachexia.22 Further, we have demonstrated
that electro-transfer of Merg1a alone into the SKM of
weight bearing mice induces atrophy and, importantly,
that electro-transfer of Merg1a into mouse SKM upregulates UPP activity. More recently, we have shown
that electro-transfer of Merg1a into mouse SKM up-

regulates the expression of the E3 ligase Murf1, but not
Mafbx/ATROGIN1.22 Because of its link to atrophy
with both unweighting and cachexia, we asked if
Merg1a expression would also modulate expression of
the Ubr2 E3 ligase gene. Here, we have determined the
time course of Merg1a and Ubr2 expression in
response to both hind limb suspension and electrotransfer of the Merg1a K+ channel and show that,
although Ubr2 is expressed in response to hindlimb
suspension, its expression is not modulated by Merg1a
expressed alone.

Materials and Methods
Animals. The Purdue Animal Care and Use Committee
approved all procedures. ND4-Swiss Webster male
mice at 8 weeks age (Harlan-Sprague; Indianapolis,
IN) were used in all procedures. Animals were
provided food and water ad libitum, housed in Purdue
University animal facilities on a 12 hour light/dark
cycle and monitored by lab animal veterinarians. At
completion of all studies, anesthetized animals were
humanely killed according to the approved protocol
prior to harvest of the gastrocnemius muscles (GMs).
Hind Limb Suspension. Custom suspension cages were
assembled as described earlier.23 Animals were
positioned in these cages resting in an approximate 30
head down tilt with their hind limbs raised off of the
floor so that they were unable to place any weight on
them. Commercial mouse cages were used to house
control mice in a natural weight bearing state.
Tissue Sectioning, Staining and CSA Determination.
GMs were embedded using OCT™ (Electron
Microscopy Sciences; Hatfield, PA), cryo-sectioned
(12 m) and stained for β–galactosidase (LACZ)
activity as described previously.21 Images of sections
were captured with a Leaf Micro–Lumina digital
camera (Scitex; Tel-Aviv, Israel). The CSA (m2) of
each muscle fiber was determined using a micrometer
slide and Image J software (NIH; Bethesda, MD).
Plasmids. The Merg1a clone in pBK/CMV24 was a
generous gift from Dr. Barry London (Cardiovascular
Institute, University of Pittsburgh, PA). The CMVlacZ in pNL vector was purchased from the Center
Commercial de Gros (Toulouse, France).
Electro-transfer. Mice were anesthetized using 10 l/g
body weight of xylazine (1 mg/ml) and ketamine (9
mg/ml) in sterile saline according to an approved
protocol. Hind limbs were shaved and the both GMs
were injected with expression plasmid (see Study 2
below) in 50 l sterile saline. Eight electrical pulses at
200V/cm for 20 ms at 1 Hertz were applied to all lower
limbs (GMs) with an ECM 830 ElectroSquare Porator
(BTX; Hawthorne, NY). This method results in gene
transcription and translation in SKM in our
laboratory.22,23,25
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DNase I (ProMega; Madison, WI) and the DNase was
subsequently heat inactivated. A GoScript™ Reverse
Transcriptase Kit (ProMega; Madison, WI) was used to
reverse transcribe cDNA using an Eppendorf
Mastercycler Personal (Hauppauge, NY). PerfeCTa
SYBR Green Supermix for iQ (Quanta Biosciences,
Inc.; Gaithersberg, MD) was added to the PCR reaction
(per manufacturer’s instructions) and primers (see
Table 1) for the gene of interest were added to the
samples (in triplicate) while primers for an appropriate
“housekeeping” gene (the 18S ribosomal subunit) were
added to identical samples (in triplicate). A BioRad
MyiQ single Color Real time PCR Detection System
(BioRad; Hercules, CA) was used to detect SYBR
Green fluorescence as a measure of amplicon. Sample
CT values were normalized to (subtracted from) the
CT values of the 18S “housekeeping” gene and the
number 2 was raised to a power equal to the difference
between the sample CT values of the 18S subunit and
the gene of interest.22,23,25
Study 1 Experimental Design. Three groups of five
mice each were hindlimb suspended22 for either 2, 4 or
7 days. A fourth group of five mice were allowed to
remain weight bearing and were used as day 0 controls
(n=20). After the assigned control or suspension
duration, each group of mice was killed according to
the approved protocol and the GMs were harvested and
flash frozen in liquid nitrogen. The left GMs from all
mice were prepared for real time PCR and thus assayed
for expression of Merg1a and Ubr2 genes (see above).
Normalized sample CT values for the Day 0 control
were averaged and the fold increase in gene expression
for each gene per mouse was determined by calculating
the ratio of each daily mouse sample gene expression
value to the average Day 0 value.
Study 2 Experimental Design. All GMs of 20 mice (4
groups of 5 each) were injected with 10 g LacZ and
20 g Merg1a expression plasmid and were subjected
to electro-transfer as described above. A group of 5
mice each was killed at days 0, 2, 4 and 7 after electrotransfer22,23,25 and the GMs from all legs were
harvested and flash frozen in liquid nitrogen. The GMs
from the left legs were cryo-sectioned and stained for
LACZ activity as a marker for gene expression while
right legs were prepared for real time PCR as described
above. Because a greater abundance (2X) of Merg1a
than LacZ expression plasmid was injected, we assume
that all myofibers staining for LACZ reporter activity
also express Merg1a and that those myofibers not
staining for LACZ activity are not expressing plasmid.
Statistics. Data were analyzed by ANOVA using a
completely randomized design. When significant
differences were found, means were separated by
Fisher's Protected Least Significant Difference. All
data were analyzed using the General Linear Model
Procedure of SAS (SAS Institute Inc.; Cary, NC). All
statements of significance are p≤0.05.

Figure 1. Hind limb suspension causes SKM
atrophy and up-regulation of both
Merg1a and Ubr2 E3 ligase expression.
Real Time PCR. Trizol reagent (Invitrogen; Carlsbad,
CA) was used to extract total RNA from GMs
according
to
manufacturer’s
instructions.
Phenol/chloroform extraction and ethanol precipitation
sequentially followed the extraction. Contaminating
DNA was degraded by two 10 min treatments with

- 175 -

Hind Limb Suspension, but not Merg1a, Yields Ubr2 Expression
Eur J Trans Myol - Basic Appl Myol 2014; 24 (3): 173-179

Results and Discussion
Study 1. Hind limb suspension causes SKM atrophy
and up-regulation of both Merg1a and Ubr2 E3 ligase
expression.
Similar to earlier studies conducted in our laboratory,22
hindlimb suspension caused decreases in myofiber
CSA at Day 2 (2%) and Day 4 (8.7%), but the
decreases are not statistically significant (Figure 1B).
The 25.6% decrease at Day 7, however, is statistically
significant. Also, similar to other studies we have
conducted,23 hind limb suspension does not result in a
statistically significant increase in Merg1a K+ channel
expression at Day 2; however, it does result in a
significant 8-fold increase in the expression of the
Merg1a K+ channel by Day 4 (Figure 1A). The level of
Merg1a K+ channel transcript decreases from that of
Day 4 by Day7 although it remains significantly higher
(4.1 fold) than Day 0.
Study 2. Ectopic expression of the Merg1a K+ channel
gene induces atrophy, but not expression of the gene
encoding the Ubr2 E3 ligase. Reminiscent of earlier
work in our laboratory,22 myofiber CSA drops by 3.1%
(Figure 2B) after 4 days of Merg1a ectopic expression.
Myofiber CSA drops by a statistically significant
15.3% after seven days of Merg1a expression,
demonstrating that Merg1a expression induces SKM
atrophy. In response to injection of Merg1a expression
plasmid into GM followed by electro-transfer, Merg1a
transcript is produced as shown earlier.22,23,25 Levels of
this transcript increase 1.7-fold by Day 2 and then to a
statistically significant higher 6.2 fold level by Day 4.
The Merg1a transcript level drops by day 7, but is still
a significant 3.8 fold higher than it was at Day 0
(Figure 2A). In contrast, Ubr2 gene expression does
not increase in response to ectopic Merg1a gene
expression. SKM atrophy occurs as a result of an
imbalance in protein synthesis and protein degradation
which ultimately favors protein loss and muscle
deterioration. The UPP, comprised of E1, E2 and E3
enzymes, is reported to be responsible for a large
portion of the protein degradation that occurs in
atrophying muscle.1-6 The E3 ligases MURF1 and
Mafbx/ATROGIN1 are ring finger E3 ligases specific
to striated muscle which contribute greatly to skeletal
muscle atrophy induced by numerous factors.1-4
Our laboratory reported that the Merg1a K+ channel is
expressed at high levels in the GMs of mice
experiencing atrophy as a result of both hind limb
suspension and cancer cachexia while it is basically
undetected in the matched muscles of appropriate
control animals.22 We have also shown that the atrophy
resulting from hind limb suspension can be inhibited
by ectopic expression (resulting from electro-transfer)
of the dysfunctional Merg1a mutant, DN-Merg1a, in
the GMs as well as by treatment with astemizole, a
known pharmacological ERG1 channel blocker.
Further, electro-transfer of the Merg1a K+ channel

Figure 2. Ectopic expression of the Merg1a K+
channel gene induces atrophy, but not
expression of the gene encoding the
Ubr2 E3 ligase.
gene into mouse GM induces atrophy and, importantly,
increases UPP activity.22 The mechanism(s) by which
MERG1a modulates UPP activity is not known;
however, we recently demonstrated that Merg1a
expression does not modulate expression of
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Mafbx/ATROGIN1, although it does indeed increase
the levels of both MURF1 transcript and protein.23
This separation of MURF1 and Mafbx/ATROGIN1
modulation at the level of a membrane protein is most
interesting. Because the literature reports that Murf1
transcription, and not that of Mafbx, is increased by
NF-B factors26 and that NF-B is basically required
for disuse muscle atrophy26-28 this separation of E3
ligase modulation suggests that MERG1a may be
modulating Murf1 expression through NF-B activity.
Indeed, a study by Wang et al. (2002), reveals that
cells expressing HERG have higher endogenous levels
of the active form of NF-B than those cell lines with
little to non-detectable levels of endogenous HERG.29
Certainly these findings beg for further exploration
into the potential effect of MERG1a on the NF-B
family of transcription factors (likely through the IKK/IB-/NF-B pathway) as well as the potential
modulation of FOXO1 and 4 transcription factors
(potentially through the PI3K/AKT/FOXO pathway).
1,4,26,30
Obviously, the MERG1a K+ channel may also
interact with other known or unknown pathways.
Our data show that hind limb suspension decreases
mouse GM CSA by 25.6% while ectopic Merg1a
expression alone induces an approximately 10% lower
(15.3%) decline in GM CSA. This demonstrates that
Merg1a expression and the consequences of this
channel up-regulation are not solely responsible for
SKM atrophy. Indeed, we have already shown that
Merg1a expression does not induce expression of
Mafbx/Atrogin1,23 an E3 ligase known to be
responsible for a large percentage of SKM atrophy
induced by immobilization,30 although it does induce
expression of MuRF1,23 another E3 ligase important to
immobilization induced SKM atrophy.30 To further
explore the potential effects of Merg1a expression on
SKM and its contributions to the atrophic process, we
decided to determine if a member of the UBR family
of ligases, known to be involved in SKM atrophy, is
modulated by MERG1a. The UBR1 and UBR2 E3
ligases are two members of the UBR family (recently
described as having 7 constituents) which are known to
recognize substrate proteins having a destabilizing Nterminal residue and an internal lysine residue for
ubiquitin conjugation.31 Expression of these E3 ligases
is induced in skeletal muscle undergoing atrophy as a
result of cancer cachexia, although Ubr2 is upregulated earlier in the atrophic time course and also
more dramatically and more specifically than Ubr1.20
In fact, Ubr2 up-regulation in the GMs of mice bearing
malignant tumors is reported to occur within the time
frame during which Merg1a expression is highest in
both suspended mice and in those expressing Merg1a
as a result of electro-transfer (during the first 7 days).
The reported Ubr1 expression time frame for cachectic
mice (second week) does not correlate well with the
Merg1a expression time courses we have reported for

either hind limb suspended or mice ectopically
expressing Merg1a.23 The existing data suggest that
Merg1a levels would be low when Ubr1 levels are
demonstrated to begin to increase, so that the increase
in Ubr1 transcript levels would not likely be a direct
result of Merg1a expression.
Although, it is possible that the time course for
Merg1a expression is more drawn out in mice
experiencing muscle atrophy as a result of cancer
cachexia, we nonetheless designed Ubr2 specific
primers and monitored the time course of Ubr2
expression in response to both hind limb suspension
and electro-transfer of Merg1a into the GMs of mice.
We discovered that, although hind limb suspension
does induce transcription of both Merg1a and Ubr2
within seven days of suspension, Merg1a expression
alone is not sufficient to yield increased levels of Ubr2
transcript within this time frame. One might speculate
that the electro-transfer of Merg1a into GMs needs
additional time for insertion of this K+ channel into the
plasma membrane and physiological activation.
However, our earlier work,22,23 demonstrated that the
time frame applied (7 days post electro-transfer of
Merg1a) does indeed produce both transcription
(rtPCR) and translation (western blotting) of the
Merg1a construct and a statistically significant 16%
(p<0.05) decrease in GM CSA. We also have shown
that this decrease in CSA can be inhibited by coelectro-transfer and co-expression of Merg1a and a
dominant negative (i.e., dysfunctional pore mutant)
form of the Merg1a channel 7 days after electrotransfer into skm.22 The inhibition of Merg1a-induced
atrophy by this dysfunctional pore mutant
demonstrates that the electro-transferred Merg1a K+
channel is functional. Further, we have shown that
both pharmacological treatment of mice with an ERG
channel pore blocker (oral gavage with astemizole) and
electro-transfer of the dominant negative Merg1a into
GM of hind limb suspended mice inhibited atrophy
(i.e., inhibited the decrease in muscle fiber CSA,22).
This evidence demonstrates (albeit indirectly) that the
MERG1a channel is functional (located in the
membrane and conducting current) within 7 days of
electro-transfer. Therefore, it appears that Merg1a
expression alone does not affect expression of Ubr2
within 7 days; nonetheless, it is still feasible that an
even longer post electro-transfer time frame may be
necessary for adequate activation of the MERG1a
channel to induce Ubr2 transcription. Further, this
work does not rule out the possibility that MERG1a
may affect or interact with some other factor produced
during hind limb suspension which induces or
participates in the induction of Ubr2 expression. For
example, HERG protein and current expression is
known to be regulated by kinases such as stressresponsive serum- and glucocorticoid-inducible kinase
isoforms SGK1 and 3 in HEK cells,32 protein kinase
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A and AMP-dependent protein kinase (AMPK; 1). It
is possible that such a factor(s) is necessary to
modulate channel activity and produce atrophy and,
although present during hindlimb suspension, is not
present when Merg1a is electro-transferred into
muscle. We also must consider that the electro-transfer
itself could interfere with the presence or production of
some factor necessary for MERG1a-induced Ubr2
transcription, although we have not produced or read
any evidence of this. Of course, even though we have
shown that our system of Merg1a electro-transfer into
mouse GMs will induce transcription of significant
levels of Merg1a and the MuRF1 E3 ligase,22,23 the
simplest issue may be that it may not have produced
the levels of MERG1a necessary to induce Ubr2
transcription.
Finally, our work does not rule out the possibility that
MERG1a may affect Ubr2 expression in muscle
atrophying as a result of cancer cachexia. Previous
studies support the existence of potential cellular
connections between UBR2 and ERG. For example,
Ubr2 expression is reported to activate the proinflammatory cytokine tumor necrosis factor-alpha
(TNF-), which is involved in the onset of
cachexia;11,29 and, interestingly, TNF- stimulation of
TNF receptor 1 (TNFR1) has been shown to impair
human ERG (HERG)/IKr current density (and prolong
action potential duration) by stimulation of reactive
oxygen species in canine cardiomyocytes.33 Is it
possible that TNF- binds its receptor and affects ERG
in such a way as to affect Ubr2 expression? Work by
Wang et al., (2002) demonstrates that TNF- affects
cell growth and apoptosis more stringently in cells
expressing ERG than those that do not, suggesting that
TNFR1 may be more abundant in the ERG-expressing
cells.34Further, it is reported that cells positive for
endogenous ERG protein also contained more
abundant TNFR1 than cells that did not express high
levels of endogenous ERG, suggesting that perhaps
ERG channels somehow recruit TNFR1 to the cell
membrane. Indeed, the same study showed that HERG
and TNFR1 co-immunoprecipitate from cell lysates.34
Therefore, it does seem reasonable to suggest that,
although Merg1a expression alone may not induce
Ubr2 expression, it may do so as a result of some
missing factor that may be more significantly abundant
under physiological atrophy producing conditions.
To our knowledge, this is the first report of an increase
in Ubr2 expression in SKM as a response to disuse
atrophy and also the first exploration of possible
modulation of Ubr2 E3 ligase expression by MERG1a.
We conclude that, although hind limb suspension of
mice induces an increased expression of genes
encoding Merg1a and Ubr2 in GMs, the electrotransfer (and subsequent expression) of Merg1a alone
into GMs of mice does not affect expression of Ubr2
within 7 days of electro-transfer. The data suggest that

either Merg1a does not affect Ubr2 expression or that,
if it does, then it either needs more than 7 days to
induce this expression or it must have access to another
factor, one induced by conditions produced during
skeletal muscle atrophy resulting from disuse and/or
cancer cachexia.
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